Wright Investors Service Comprehensive Report for Astellas Pharma Incorporated
10 Oct 2016
Available for Immediate Download
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality RatingÂ® analyses tables. The Wright Quality Rating measures the liquidity of the stock and the financial strength, profitability and corporate growth characteristics of Astellas Pharma Incorporated A textual review of the financial results of Astellas Pharma Incorporated versus Otsuka Holdings Company Limited, Daiichi Sankyo Company Limited and Takeda Pharmaceutical Company Limited is includedrepo. The comparative analysis,of these companies,compares Sales, Company Valuations and Financial Position. Also included for Astellas Pharma Incorporated are: Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and key data items. Additional research for Astellas Pharma Incorporated includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices. The companyâ€™s financial results are compared in a series of reports (i.e. financial statements, sales, key ratios, etc.) to global industry averages.